Biofrontera (BFRI) Gross Profit (2020 - 2025)

Biofrontera's Gross Profit history runs 6 years deep, the most recent figure standing at $14.1 million for Q4 2025.

• On a quarterly basis, Gross Profit rose 93.35% year-over-year to $14.1 million in Q4 2025; TTM through Dec 2025 was $30.7 million, a 64.26% increase from a year earlier, with the FY2025 full-year figure at $30.7 million, up 64.27% from the prior year.
• Gross Profit grew to $14.1 million in Q4 2025 per BFRI's latest filing, from $4.9 million in the prior quarter.
• Across five years, Gross Profit topped out at $14.1 million in Q4 2025 and bottomed at -$15.1 million in Q4 2021.
• The 5-year median for Gross Profit is $4.4 million (2021), against an average of $4.4 million.
• Biggest YoY gain for Gross Profit was 263.03% in 2023; the steepest drop was 56.29% in 2023.
• Year by year, Gross Profit stood at -$15.1 million in 2021, then soared by 51.31% to -$7.3 million in 2022, then surged by 263.03% to $12.0 million in 2023, then sank by 39.02% to $7.3 million in 2024, then soared by 93.35% to $14.1 million in 2025.
• Per Business Quant, the three latest BFRI Gross Profit figures stand at $14.1 million (Q4 2025), $4.9 million (Q3 2025), and $6.4 million (Q2 2025).